Login

Transport Infrastructure Group Before Discussing R&D Site Strategic Factors in Magny-les-Hameaux | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Dish and EchoStar chairman Charlie Ergen, alongside EchoStar CEO Hamid Akhavan, join 'Squawk on the Street' to discuss Ergen's rationale behind the decision to merge.|Hamid Akhavan is the President and CEO of DISH and EchoStar
00:10:00
Sidley Austin's Partner Compensation and Key to Firm Survival | Michael J. Schmidtberger - Chair of Sidley Austin LLP
00:10:00
Closing the gender gap in VC funding|Eve Burton,Chairwoman HearstLab,HearstLab
00:10:00
Exploring Mali's Potential: Insights from a Gold-focused Company at the One-to-One Conference
00:10:00
Investigating Hydrogen Technology at Ampol | Steven Gregg, Chairman, Ampol LtdALD:NZC
00:10:00
Finding Solutions for your Capital Needs|Chris Oberbeck,Chairman,Saratoga Partners
00:10:00
Perion Network (PERI) CEO Doron Gerstel dismisses industry challenges in an interview with Oliver.
00:10:00
Roger McNamee Critiques Generative AI's Overhyped Potential and Real-world Impact |Roger McNamee, Co-Founder, Elevation Partners.
00:10:00
Viva Gold Corp. Presents Tonopah Gold Project: High-Grade Potential and Robust Economics
00:10:00
Jean-Claude Maurel Shares Optimism and Insights on Enhancing SME Financing | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:00:00
Medical Education Research Specialist, / Edward Krupat, PhD Professor, Masters in Dental Education Program, Harvard School of Dental Medicine
00:10:00
Fubo CEO David Gandler discusses the company's 4Q earnings and the competitive landscape of sports streaming with Diane King Hall.

© 2026 Nehu